Outcomes Analysis of Patients Receiving Local Ablative Therapy for Oligoprogressive Metastatic NSCLC Under First-Line Immunotherapy
Author:
C. Huet,C. Basse,M. Knetki-Wroblewska,P. Chilczuk,PE. Bonte,S. Cyrille,E. Gobbini,P. Du Rusquec,M. Olszyna-Serementa,C. Daniel,F. Lucibello,L. Lahmi,M. Krzakowski,N. Girard
Publication:
Clinical Lung Cancer
© 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.